(Q80853383)

English

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

scientific article published on 01 December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

based on heuristic

inferred from title

acute lymphocytic leukemia

1 reference

based on heuristic

inferred from title

adult acute lymphocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hagop Kantarjian

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Deborah Thomas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Susan O'Brien

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jorge Cortes

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Francis Giles

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Sima Jeha

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Carlos E Bueso-Ramos

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Sherry Pierce

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jianqin Shan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Charles Koller

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Miloslav Beran

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Michael Keating

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Emil J Freireich

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

101

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2788-2801

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

The biology and therapy of adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

The Medical Research Council trials in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

The hyper-CVAD regimen in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Physician compliance and relapse rates of acute lymphoblastic leukemia in children.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival for childhood acute lymphoblastic leukemia: possible effect of protocol compliance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

HyperCVAD for VAD-resistant multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20668

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20668

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15481055%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80853383&oldid=2037668729"